1. Home
  2. RILY vs EIKN Comparison

RILY vs EIKN Comparison

Compare RILY & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RILY

B. Riley Financial Inc.

N/A

Current Price

$3.98

Market Cap

349.8M

Sector

Finance

ML Signal

N/A

Logo Eikon Therapeutics Inc. Common Stock

EIKN

Eikon Therapeutics Inc. Common Stock

N/A

Current Price

$6.77

Market Cap

316.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RILY
EIKN
Founded
1973
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
349.8M
316.3M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
RILY
EIKN
Price
$3.98
$6.77
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $24.33
AVG Volume (30 Days)
★ 866.1K
525.7K
Earning Date
11-05-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 138.49
N/A
EPS
★ N/A
N/A
Revenue
★ $967,599,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 15.38
N/A
52 Week Low
$3.49
$5.01
52 Week High
$11.24
$16.50

Technical Indicators

Market Signals
Indicator
RILY
EIKN
Relative Strength Index (RSI) 40.25 50.02
Support Level N/A $5.01
Resistance Level $4.54 $8.48
Average True Range (ATR) 0.28 0.70
MACD 0.04 0.13
Stochastic Oscillator 43.54 55.39

Price Performance

Historical Comparison
RILY
EIKN

About RILY B. Riley Financial Inc.

BRC Group Holdings Inc is a diversified holding company offering a platform of businesses, including financial services (with complementary banking and wealth management businesses), telecom, retail, and investments in equity, debt, and venture capital. It serves retail, corporate, capital providers, and individual customers across different business lines. The Group reports its activities in seven reportable business segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Maximum revenue is generated from the Consumer Products segment, which offers mobile computing accessories and home furnishing products. Geographically, the Group derives its revenue from North America.

About EIKN Eikon Therapeutics Inc. Common Stock

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Share on Social Networks: